Emergent BioSolutions to Participate in Virtual Investor Conferences - Aug 18, 2020

GAITHERSBURG, Md., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following virtual investor conferences through the end of September 2020:

  • 2020 NYSE Healthcare & Technology Investor Access Day
    August 18 – virtual one-on-one meetings only
  • 2020 Three Part Advisors Virtual Midwest IDEAS Investor Conference
    August 27 – pre-recorded presentation available beginning at 8:00am eastern
  • 2020 Wells Fargo Virtual Healthcare Conference
    September 9 – presentation at 8:00am eastern
     
  • Robert W. Baird 2020 Global Healthcare Conference
    September 10 – presentation at 2:35pm eastern
     
  • Morgan Stanley 18th Annual Global Healthcare Conference 2020
    September 14 – presentation at 4:30pm eastern
     
  • Cantor Virtual Global Healthcare Conference 2020
    September 15 – presentation at 3:20pm eastern
     
  • 2020 Singular Research Compelling Values Webcall
    September 17 – presentation at 12:00pm eastern

For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”

About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information visit www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com

Media Contact:
Miko B. Neri
Senior Director, Global Communications & Public Affairs
240-631-3392
nerim@ebsi.com

Primary Logo

Back to news